Opioid Users Report Relief from an Experimental Drug Now Banned by the DEA
People with opioid addiction are reporting that an experimental drug called SR-17018 can alleviate withdrawal symptoms, describing its effects in online communities on Reddit and Discord.
The claims come from users rather than established clinical findings. Still, the reported potential has drawn attention to the drug as regulators consider its legal status.
The Drug Enforcement Administration has placed SR-17018 in the same regulatory category as heroin, effectively banning its use outside approved research. The scheduling decision creates tension between the experiences of people seeking relief from withdrawal and the DEA’s assessment of the drug’s risks and lack of approval.
The dispute highlights the limitations of relying on anecdotal accounts while also showing how online patient communities are identifying treatments that have not yet received broader clinical or regulatory approval.